April 29, 2025 11:40 AM EDT
Health Tech

In­side De­vot­ed Health’s 2024 fi­nan­cials

Lydia Ramsey Pflanzer

Deputy Editor

Every spring I ask Shel­by a very fun ques­tion: Is it time to look at in­sur­ance fil­ings?

This year, that in­clud­ed comb­ing through the 33 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

FDA de­lays PDU­FA date for small biotech, rais­ing ques­tions about im­pact of agency cuts

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

FDA won't re­or­ga­nize med­ical prod­uct cen­ters, Makary says in in­ter­view: 'I re­ject­ed that pro­pos­al'

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times